China closing in but US still leads in biotech innovation, survey finds (opens in new tab)

China, which now conducts more clinical drug trials than the U.S., still lags in several key areas of biotechnology innovation, according to a recent survey of senior U.S. leaders in industry and academia. The ​poll, conducted by Cure Innovation Index, found that China is seen as the clear leader in ‌two out of six sectors: […] The post appeared first on <a href="